Odaily Planet Daily reports that YZi Labs is reviewing the response actions taken by CEA Industries in the written consent solicitation process initiated by YZi Labs. These actions include adopting a poison pill plan and amending the company’s bylaws, aimed at thwarting and delaying shareholder rights. YZi Labs believes that the board’s purpose is to consolidate its own position, and the 2025 annual meeting has now been postponed to after the anniversary on December 17. Additionally, YZi Labs refutes CEA Industries’ statement that it has never considered an alternative token strategy, pointing out that CEO David Namdar explicitly stated at an industry conference in November 2025 that the company was considering shifting to assets like Solana. YZi Labs urges the board to avoid further operational actions and to ensure fairness in the director nomination and election process.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
YZi Labs: Condemns the CEA Industries Board of Directors for adopting a poison pill plan and depriving shareholders of rights
Odaily Planet Daily reports that YZi Labs is reviewing the response actions taken by CEA Industries in the written consent solicitation process initiated by YZi Labs. These actions include adopting a poison pill plan and amending the company’s bylaws, aimed at thwarting and delaying shareholder rights. YZi Labs believes that the board’s purpose is to consolidate its own position, and the 2025 annual meeting has now been postponed to after the anniversary on December 17. Additionally, YZi Labs refutes CEA Industries’ statement that it has never considered an alternative token strategy, pointing out that CEO David Namdar explicitly stated at an industry conference in November 2025 that the company was considering shifting to assets like Solana. YZi Labs urges the board to avoid further operational actions and to ensure fairness in the director nomination and election process.